Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

NASDAQ:VERA

Overview | Financials
Company Name Vera Therapeutics, Inc.
Symbol VERA
Currency USD
Price 43.82
Market Cap 2,402,549,814
Dividend Yield 0%
52-week-range 9.83 - 50.78
Industry Biotechnology
Sector Healthcare
CEO Dr. Marshall Fordyce M.D.
Website https://veratx.com

An error occurred while fetching data.

About Vera Therapeutics, Inc.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A

Related Stocks

908 Devices Inc. logo

908 Devices Inc.

MASS

3.46 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.282 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

2.06 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.297 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

18 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.3 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

14.65 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

4.4 USD

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

2.61 USD

Financials

Numbers are in millions USD

Numbers are in millions USD